Drug manufacturer Eli Lilly cuts insulin prices after public and political backlash. Insurtech Bright Health tells investors it needs to raise $300 million to stay afloat. And, greater numbers of younger people are being diagnosed with advanced cases of colorectal cancers, according to a new study. That's coming up on today's episode of Gist Healthcare Daily.
